University of Utah
BioResearch Product Faire™
About 1 in every 100 babies born have a congenital heart defect (CHD), a structural defect of the heart. In fact, CHDs are the most common types of birth defect. In one quarter of the cases the condition is serious enough to require surgery or other procedures within the first year of life. Despite the frequency, the cause of most congenital heart defects remains a mystery. And without knowing the cause, scientists are not been able to find a way of preventing these defects.Read More
35 years in the making, the grand opening was recently announced for then new University of Utah School of Dentistry (SOD) Ray and Tye Noorda Oral Health Sciences Building.
The new $36 million, 85,000-square-foot Research Park building will includeRead More
Leukemia is a cancer that’s unusual in that it begins in the bone marrow and invades the blood. The most prominent treatment options – drugs called tyrosine kinase inhibitors – have allowed for a 95 percent survival rate over the past five years and also allow leukemia patients to lead relatively normal lives.
"Fortunately, the problems we are studying affect a minority of chronic myeloid leukemia patients, but still, this leaves some patients with no good treatment option at all," said lead author and University of Utah life science researcher Dr. Thomas O'Hare. "Our goal is to have a tyrosine kinase inhibitor option for every patient."Read More
Research funding at the University of Utah is on the rise with the latest news of new NIH life science funding awarded to researchers this year. The National Institutes of Health awarded the University of Utah $2.7 million for studies involving data coordinating at the Center for the Collaborative Pediatric Critical Care. The departments receiving this latest research funding include Pediatrics and the School of Medicine. The funding organization within the National Institutes of Health is the Eunice Kennedy Shriver National Institute of Child Health & Human Development.
Professor of Pathology, John H. Weis, at the University of Utah School of Medicine analyzed the DNA of 140 patients with Kawasaki disease to discover that those with the genetic variation in the IFITM3 gene were significantly more likely to develop coronary artery lesions or enlargement. This discovery has significant implications on the understanding of Kawasaki disease and highly contributes to the global health improvement.
Researchers at the University of Utah, Salt Lake City recently received $3.1 million in life science funding from the NSF. According to the University of Utah, the scientists receiving this funding include Denise Dearing and Dale Clayton, who have both won individual five-year grants.
Lab suppliers working to sell lab equipment and increase life science sales leads at Utah life science marketing events may be interested in the latest grant news at the University of Utah. Researchers studying metabolic disorders such as obesity, diabetes and metabolic syndrome have received a $2.5 million award from the NIH. According to the NIH RePORTER, the study, titled “Reprogrammed Platelets: Effectors of Thrombosis in Metabolic Syndromes,” will be led by University of Utah internal medicine researcher Andrew S. Weyrich, Ph.D. The project’s abstract states:
Lab suppliers marketing life science solutions and hoping to generate lab sales leads may find the latest research funding news at the University of Utah offers insight into a compelling market. The University of Utah has recently been approved for $1.9 million in research funding from the Patient-Centered Outcomes Research Institute (PCORI). The award will be used for a project in which researchers study asthma in children and how more effectively monitoring the disease could lead to better health.
The University of Utah College of Pharmacy just celebrated the opening of its new 150,000sf research building, the L.S. Skaggs Pharmacy Institute, on Medical Drive South. Located adjacent to the 1965 facility named after the senior Mr. Skaggs, the newly-expanded research institute will continue to advance drug development and teaching excellence, much the way the first Skaggs building vaulted the University into the ranks of top pharmaceutical colleges within a few years of its construction. The college currently ranks #10 out of 125 doctor of pharmacy programs according to US News & World Report. The NIH ranks it #3 in research productivity, and it has been among the top 4 pharmacy colleges in NIH funding every year since 1975. 2012 NIH funding was over $20M. The Skaggs family, through their charitable organization, the ALSAM Foundation, gave $50M towards the building costs of the institute.
Tags: 2014, 2013, Utah, university of utah, UUtah, Pharmacology, UТ, New research facilities, new science wet labs, Southwest, BioResearch Product Faire Event, Front Line event, Salt Lake City, New Labs